SCHEMBL16747360

SCHEMBL16747360

CCCCOc1cn(OCCCC)c(C(=O)Nc2ccc(C(=O)OC(C)(C)C)cc2)cc1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 1/20 0.41
CASP1 P29466 1/20 0.41
MAPT P10636 7/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
STAT3 P40763 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 1/20 0.40
HPGD P15428 3/20 0.39
TP53 P04637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
RECQL P46063 1/20 0.39
LMNA P02545 1/20 0.38
MAPK14 Q16539 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
PPARA Q07869 1/20 0.38
GPR35 Q9HC97 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9915520 0.87 NR1H4 (0.45) MEN1KMT2ARAB9ANPC1CASP1
SCHEMBL14124972 0.82 KMT2A (0.45) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL16747452 0.80 PTPRC (0.36) MAPTKDM4E
SCHEMBL16747359 0.79 MAPT (0.44) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL9915325 0.78 SMN1; SMN2 (0.43) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL9915519 0.78 MEN1 (0.44) MEN1KMT2ARAB9ANPC1CASP1
SCHEMBL9915523 0.75 C5AR1 (0.39) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL9915333 0.74 PTPRC (0.40) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL9915434 0.74 NR1H4 (0.44) SMN1; SMN2TP53LMNA
SCHEMBL16747451 0.73 ALDH1A1 (0.40) MEN1KMT2AALDH1A1TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150148326-A1 Monobactams PFIZER (US) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148326-A1 Monobactams MGAM, MGAM2, BPGM MEN1 2023/4885KMT2A 608/4885RAB9A 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.